Diabetes in heart failure: Prevalence and impact on outcome in the population

被引:233
作者
From, Aaron M.
Leibson, Cynthia L.
Bursi, Francesca
Redfield, Margaret M.
Weston, Susan A.
Jacobsen, Steven J.
Rodeheffer, Richard J.
Roger, Veronique L.
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Hlth Sci Res, Rochester, MN 55905 USA
关键词
heart failure; diabetes mellitus; coronary disease;
D O I
10.1016/j.amjmed.2006.05.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: Little is known on the prevalence and prognostic importance of diabetes mellitus (DM) among individuals with heart failure (HF) in community-based cohorts. METHODS: Within Olmsted County, Minnesota, a random sample of all subjects with a first diagnosis of HF between 1979 and 1999 was validated using Framingham criteria. DM was validated using glycemic criteria. RESULTS: Among 665 subjects with HF (mean age 77 +/- 12 years, 46% male), 20% had prior DM. Subjects with DM were younger, had greater body mass index (BMI), and lower left ventricular ejection fraction than subjects without diabetes. The prevalence of DM increased markedly over time (3.8% per year; 95% confidence interval [CI], 0.8 to 6.9; P = .024), independently of BMI, particularly in older subjects (odds ratio of having DM in 1999 compared with 1979 was 3.93 [95% CI, 1.57 to 9.83] in subjects >= 75 years vs. 1.11 [95% CI, .40 to 3.05] in subjects < 75 years). Five-year survival was 37% among subjects with DM versus 46% among subjects without (P = .017). The risk of death associated with DM differed markedly according to clinical coronary artery disease (CAD) (P = .025). Subjects with DM and no CAD had a higher risk of death (relative risk [RR] = 1.79 [95% CI, 1.33 to 2.41]) than those with CAD (RR = 1.11 [95% CI, .81 to 1.51]), independently of age, sex, BMI, renal function, calendar year of HF, comorbidity and EF. CONCLUSIONS: Among community-dwelling patients with HF, the prevalence of DM increased markedly over time. DM is associated with a large increase in mortality, particularly among subjects without clinical CAD, underscoring the importance of aggressive management of DM in HF. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:591 / 599
页数:9
相关论文
共 52 条
  • [1] ABBOTT RD, 1986, JAMA-J AM MED ASSOC, V260, P3456
  • [2] Diabetes and idiopathic cardiomyopathy - A nationwide case-control study
    Bertoni, AG
    Tsai, A
    Kasper, EK
    Brancati, FL
    [J]. DIABETES CARE, 2003, 26 (10) : 2791 - 2795
  • [3] Predictors of heart failure among women with coronary disease
    Bibbins-Domingo, K
    Lin, F
    Vittinghoff, E
    Barrett-Connor, E
    Hulley, SB
    Grady, D
    Shlipak, MG
    [J]. CIRCULATION, 2004, 110 (11) : 1424 - 1430
  • [4] Prognosis for South Asian and white patients newly admitted to hospital with heart failure in the United Kingdom: historical cohort study
    Blackledge, HM
    Newton, J
    Squire, IB
    [J]. BRITISH MEDICAL JOURNAL, 2003, 327 (7414): : 526 - 530
  • [5] Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) : 1360 - 1369
  • [6] Impact of case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota
    Burke, JP
    O'Brien, P
    Ransom, J
    Palumbo, PJ
    Lydick, E
    Yawn, BP
    Melton, LJ
    Leibson, CL
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (09) : 859 - 865
  • [7] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [8] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [9] de Groote P, 2004, EUR HEART J, V25, P656, DOI 10.1016/j.ehj.2004.01.010
  • [10] A comparative analysis of the results from 4 trials of β-blocker therapy for heart failure:: BEST, CIBIS-II, MERIT-HF, and COPERNICUS
    Domanski, MJ
    Krause-Steinrauf, H
    Massie, BM
    Deedwania, P
    Follmann, D
    Kovar, D
    Murray, D
    Oren, R
    Rosenberg, Y
    Young, J
    Zile, M
    Eichhorn, E
    [J]. JOURNAL OF CARDIAC FAILURE, 2003, 9 (05) : 354 - 363